Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Oct 14, 2019 10:00 AM ET

In Vitro Toxicology Testing Market Worth $12.7 Billion by 2024




iCrowd Newswire - Oct 14, 2019

According to the new market research report In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024″, published by MarketsandMarkets™, the In-Vitro Toxicology/Toxicity Testing Market is expected to reach USD 12.7 billion by 2024 from USD 8.1  billion in 2019, growing at a CAGR of 9.3%.

in-vitro-toxicology-testing-market5

The major factors driving the growth of this industry are the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065

By product & service, the consumables segment is expected to account for the largest share of the In-Vitro Toxicology Testing Market

The consumables segment is estimated to account for the largest In-Vitro Toxicity Testing Market share in 2018. The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in-vitro toxicology studies.

Browse in-depth TOC on “In-Vitro Toxicology Testing Market

148 – Tables
43 – Figures
253 – Pages

In the toxicity endpoints & tests segment, the organ toxicity segment is expected to grow at the highest CAGR during the forecast period

The organ toxicity segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.

Based on technology, the cell culture segment is expected to account for the largest share of the In-Vitro Toxicology Testing Market

The cell culture segment is estimated to account for the largest In-Vitro Toxicity Testing Market share in 2018. The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in-vivo conditions.

Asia Pacific is estimated to be the fastest-growing market for in-vitro toxicology testing during the forecast period

The In-Vitro Toxicity Testing Market is projected to register the highest growth during the forecast period for APAC Region. The emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the In-Vitro Toxicology Testing Market in the APAC.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065

The prominent players in the In-Vitro Toxicology Testing Market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).



Contact Information:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]






Keywords:    In Vitro Toxicology Testing Market, In Vitro Toxicology Testing

Tags:    Extended Distribution, Wire, Research Newswire, English